United Imaging Intelligence Launches uAI Integrated Solution for Precision Diagnosis and Treatment of Orthopedic Diseases

National Bone HealthIt is one of the key priorities of the national public health system. The Outline of the “Healthy China 2030” Plan explicitly calls for launching special initiatives such as the “Healthy Bones” campaign. Promoting bone health is also a key component of the National Health Commission’s “Three Reductions and Three Healthy Conditions” special initiative.

The importance of bone health issues to public health cannot be overlooked.From Healthy Skeletal Development in Childhood, to Maintaining Ideal Peak Bone Mass in Young and Middle Adulthood, to the Widespread Adoption of Fall and Fracture Prevention Measures in Old Ageetc. Bone health is directly related to human mobility and quality of life.Enhancing the Precision of Diagnosis and Treatment for Bone Diseases, which is of great significance for maintaining bone health across all age groups.

However, at the current stage, there are still some pain points in the diagnosis and treatment of bone diseases. For example, in measurement scenarios, the alignment of the lower limbs is mostly measured manually, which is time-consuming and has a low degree of data structuring; in emergency scenarios, if a patient with a fracture is encountered, doctors need to “count ribs” back and forth based on imaging films during diagnosis. If there are subtle fractures or occult fractures, they are not easy to detect and are prone to missed diagnoses, which to some extent limits the accuracy and efficiency of diagnosis and treatment.

First proposed in the 2024 "Government Work Report"“AI Plus” Initiative, AI technology is deeply integrated with various industries, particularly in the healthcare sector. In the diagnosis and treatment of bone diseases, AI has also become a key breakthrough for addressing the aforementioned pain points.Trained on imaging data, artificial intelligence can rapidly identify and quantify various conditions, including fracture trauma, bone and joint disorders, skeletal growth and development, bone mineral density, and bone metastases.Physicians can further refine their diagnoses based on quantitative data provided by AI, thereby enhancing quality and efficiency across multiple scenarios, including measurement, diagnosis, and treatment., delivering faster, more precise, and higher-quality services to patients.

Aligning with the prevailing development trends, United Imaging Intelligence Co., Ltd. (hereinafter referred to as “United Imaging”)“uAI Precision Diagnosis and Treatment Integrated Solution for Orthopedic Diseases”，Comprehensively covering multiple scenarios, including fracture trauma, joint degeneration, skeletal growth and development, quantitative bone analysis, bone metastasis, and preoperative planning, it achieves multi-modal coverage of CT and X-ray, addressing the major skeletal health issues across all age groups., aiming to provide comprehensive protection for skeletal health throughout the entire life cycle.

On Thursday, July 25, at 19:30, the 79th edition of VCBeat Select New Product Appreciation invitesWang Zhi, Director of the Department of Radiology at Tianjin Hospital in Tianjin,Dr. Dong Yun, General Manager of United Imaging Intelligence Medical Technology (Beijing) Co., Ltd., presents“uAI Precision Diagnosis and Treatment Integration Solution for Orthopedic Diseases”product promotion.

Wang Zhi

Director, Department of Radiology, Tianjin Hospital

Graduate Supervisor at Tianjin University, Tianjin Medical University, and Tianjin University of Traditional Chinese Medicine; Associate Professor at Tianjin Medical University. A national leader in the field of musculoskeletal imaging diagnosis, serving as Head of the Imaging Group of the Sarcoma Professional Committee of the China Anti-Cancer Association, Member of the Fifth Musculoskeletal Imaging Professional Committee of the Radiologist Branch of the Chinese Medical Doctor Association, Member of the Osteoporosis Branch of the China International Exchange and Promotive Association for Medical and Health Care, and holding dozens of other social positions.

Presided over and participated in dozens of research projects at the national, provincial/municipal, and bureau levels, and published dozens of papers in SCI-indexed and core journals. Research interests include the application of novel MRI techniques in the musculoskeletal system, translation of medical-engineering collaborative achievements, artificial intelligence, radiomics applications in the musculoskeletal system, bone tumors, metabolic bone diseases, and chronic and congenital bone and joint disorders.

Dr. Dong Bo

General Manager, United Imaging Intelligence Medical Technology (Beijing) Co., Ltd.

Distinguished Researcher at the School of Biomedical Engineering, ShanghaiTech University; Member of the Young Professionals Committee, Artificial Intelligence Branch of the Chinese Society of Biomedical Engineering. He received his Ph.D. from the National Institute of Applied Sciences Lyon (INSA-Lyon) in France and completed his postdoctoral research at the University of North Carolina in the United States.

With extensive expertise in the R&D of AI algorithms for medical imaging and product development, with a focus on orthopedics, cardiovascular diseases, and other specialties. Has participated in multiple national and provincial-level key research projects, including the National Key R&D Program and key projects funded by the National Natural Science Foundation of China. Has published nearly 50 papers in top-tier international journals and conferences such as IEEE TNNLS, Medical Image Analysis (MIA), and MICCAI, and has filed over 40 patents and more than 10 software copyrights.

Shanghai United Imaging Intelligence Co., Ltd. (“United Imaging Intelligence”) is the artificial intelligence subsidiary of United Imaging Group. Established in Shanghai in late 2017, it has set up subsidiaries or branch offices in Beijing, Wuhan, Chengdu, Shenzhen, and Boston, USA, and plans to establish R&D teams in Xi’an and other locations. Leveraging the high-performance software and hardware technology platform and resource advantages of United Imaging Group, United Imaging Intelligence has become a leading medical AI enterprise capable of providing multi-scenario, multi-disease, full-process, integrated intelligent solutions. It empowers medical equipment, clinical practice, and scientific research, covering various AI application scenarios such as hospital-level management, medical innovation ecosystems, workflow optimization, precision diagnosis and treatment, and personal health management. Through high-end, comprehensive medical AI innovation, it strives to promote universal well-being and health for all.

UNITED IMAGING has assembled a team of top-tier medical AI talents from both China and abroad. To date, it has launched over 10 AI platforms and more than 100 AI applications, which have been deployed in over 3,000 hospitals across China, covering the entire diagnosis and treatment workflow. Currently, its products have obtained eight Class III medical device registrations from the National Medical Products Administration (NMPA), spanning multiple fields including cardiovascular, respiratory, neurological, orthopedic, and radiotherapy. Many of its products have also received CE certification in the European Union and FDA clearance in the United States. Furthermore, UNITED IMAGING has led or participated in more than 80 national, provincial, and ministerial-level scientific research projects, and has published over 500 academic papers in the field of scientific research.

UNITED IMAGING has successively won numerous prestigious awards, including the First Prize of the China Invention and Innovation Award, the First and Second Prizes of the Beijing Science and Technology Progress Award, the First and Second Prizes of the Shanghai Science and Technology Progress Award, designation as one of Shanghai’s first “Innovative Enterprise Headquarters,” two-time recipient of the China Patent Excellence Award, three-time recipient of the Industry-University-Research Cooperation Innovation Award, the highest honor at the 2020 World Artificial Intelligence Conference—the SAIL Award (Super AI Leader), champion of the inaugural global fastMRI Image Reconstruction Challenge, and champion of the world-class SegTHOR Challenge 2019.

“Artery Select New Product Debut” is a live-streaming program under the “Artery Select” brand, dedicated to supporting medical enterprises in launching innovative products. The program’s mission is: to empower the milestone launch of every medical innovation product.

Scan the QR code below to contact the assistant and reserve a spot for the live broadcast (if you have already added the assistant, please reach out to them directly).

Scan the QR code below to download the VCBeat app and register to watch the live stream.

Contact the assistant to send a screenshot of the live stream and enter the lucky draw for a chance to win a [15-day trial membership of VBInsight Industry Think Tank].